title: Reply to: "Therapeutic drug monitoring for sofosbuvir and daclatasvir in transplant recipients with chronic hepatitis C and advanced renal disease".
authors.affiliation: Pharmacy Department, Geneva University Hospitals, HUG, Geneva, Switzerland. Electronic address: audedesnoyer@gmail.com.
authors.forename: Aude
authors.initials: A
authors.lastname: Desnoyer
authors.affiliation: Pharmaco-Toxicology Department, Bichat-Claude Bernard Hospital, APHP, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, IAME, INSERM UMR 1137, Paris, France.
authors.forename: Minh Patrick
authors.initials: MP
authors.lastname: Lê
authors.affiliation: Infectious Diseases & Tropical Department, Bichat-Claude Bernard Hospital, APHP, Paris, France.
authors.forename: Yazdan
authors.initials: Y
authors.lastname: Yazdanpanah
authors.affiliation: Pharmaco-Toxicology Department, Bichat-Claude Bernard Hospital, APHP, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, IAME, INSERM UMR 1137, Paris, France.
authors.forename: Gilles
authors.initials: G
authors.lastname: Peytavin
mesh_terms: D000998:Antiviral Agents; D002219:Carbamates; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D016174:Hepacivirus; D019698:Hepatitis C, Chronic; D006801:Humans; D007093:Imidazoles; D011759:Pyrrolidines; D000069474:Sofosbuvir; D066027:Transplant Recipients; D016896:Treatment Outcome; D014633:Valine / Q000031:analogs & derivatives
chemical_list: D000998:Antiviral Agents; D002219:Carbamates; D007093:Imidazoles; D011759:Pyrrolidines; D014633:Valine; C549273:daclatasvir; D000069474:Sofosbuvir